Among these tumor markers, Notum possessed the highest diagnostic power in discriminating early-stage GC patients and advanced patients with AUC at 0.728 (sensitivity = 82.89%, specificity = 51.79%) (Fig. 2c and d, Additional file 1: Fig. S3A and Additional file 2: Table S6). The gene discussed is NOTUM; the disease is neoplasm.